Please login to the form below

Not currently logged in
Email:
Password:

President of Lilly Oncology resigns

John H Johnson, president of Lilly Oncology has resigned effective January 28, citing personal considerations

John H Johnson, senior vice president and president of Lilly Oncology has resigned effective January 28, citing personal considerations.

Johnson was previously CEO of ImClone Systems, and joined Lilly when it acquired the cancer-focused biotech company in 2008. Lilly has not yet named a successor to lead its oncology unit, but said it will do so in the coming weeks.

Lilly chairman, president and CEO John Lechleiter said in a statement that Johnson "has guided the Lilly Oncology pipeline to an all-time high – one of the largest clinical-stage pipelines of potential cancer medicines in the industry."

Lilly Oncology's portfolio of marketed drugs includes the non-small cell lung cancer treatment Alimta and the ovarian cancer therapy Gemzar. The company has also declared a commitment to developing personalised cancer medications.

Johnson became CEO of ImClone in 2007, leaving his post as company group chairman of Johnson & Johnson's worldwide biopharmaceuticals unit, where he had responsibility for that company's biotechnology, immunology and oncology commercial businesses.

The $6.5bn acquisition of ImClone was the largest in Lilly's history. The deal was driven in large part by Lilly's desire to add ImClone's targeted cancer therapy Erbitux (cetuximab) to its portfolio.

25th January 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics